SCHEMBL17895232

SCHEMBL17895232

Nc1nc2ccc(C(F)(F)F)cc2n2c(-c3ccc(O)c(O)c3)cnc12

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALOX5AP P20292 2/20 0.36
FEN1 P39748 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PDE2A O00408 6/20 0.35
PDE10A Q9Y233 6/20 0.35
NPBWR1 P48145 1/20 0.35
PDE7A Q13946 1/20 0.35
MIF P14174 1/20 0.34
USP7 Q93009 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17895195 0.91 ALOX5AP (0.36) ADORA2AALOX5APFEN1KDM4EPDE2A
SCHEMBL17895277 0.85 MIF (0.38) ADORA2AMIF
SCHEMBL17895316 0.84 IKBKB (0.45) KDM4EPDE2APDE10APDE7A
SCHEMBL17895091 0.82 IKBKB (0.50)
SCHEMBL17895242 0.82 ADORA2A (0.45) ADORA2AMIF
SCHEMBL17895099 0.81 MAP4K4 (0.40) ADORA2AMIF
SCHEMBL17895251 0.81 IKBKB (0.45)
SCHEMBL17895315 0.80 KDM4E (0.38) ADORA2AKDM4EMIF
SCHEMBL17894995 0.79 IKBKB (0.43)
SCHEMBL17895096 0.78 PIK3CG (0.38) ADORA2AKDM4EMIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3240789-B1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIV MONTPELLIER (FR) 2020-07-29 EP claimed
EP-3240789-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER Université de Montpellier (FR) 2017-11-08 EP claimed
WO-2016107895-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIVERSITE DE MONTPELLIER (FR) 2016-07-07 WO claimed
EP-3240789-B1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIV MONTPELLIER (FR) 2020-07-29 EP disclosed
EP-3240789-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER Université de Montpellier (FR) 2017-11-08 EP disclosed
WO-2016107895-A1 NEW IMIDAZO[1,2-A]QUINOXALINES AND DERIVATES THEREOF FOR THE TREATMENT OF CANCER UNIVERSITE DE MONTPELLIER (FR) 2016-07-07 WO disclosed